Optimum chemotherapy regimen for early breast cancer

Lancet Oncol. 2011 Jun;12(6):514-5. doi: 10.1016/S1470-2045(11)70125-5.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Female
  • Humans
  • Mutation
  • Taxoids / administration & dosage
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / physiology*

Substances

  • TP53 protein, human
  • Taxoids
  • Tumor Suppressor Protein p53